Jay Rappaport

8.5k total citations · 1 hit paper
144 papers, 5.6k citations indexed

About

Jay Rappaport is a scholar working on Virology, Immunology and Molecular Biology. According to data from OpenAlex, Jay Rappaport has authored 144 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Virology, 55 papers in Immunology and 44 papers in Molecular Biology. Recurrent topics in Jay Rappaport's work include HIV Research and Treatment (76 papers), Immune Cell Function and Interaction (31 papers) and HIV/AIDS drug development and treatment (20 papers). Jay Rappaport is often cited by papers focused on HIV Research and Treatment (76 papers), Immune Cell Function and Interaction (31 papers) and HIV/AIDS drug development and treatment (20 papers). Jay Rappaport collaborates with scholars based in United States, France and Italy. Jay Rappaport's co-authors include Kamel Khalili, Tracy Fischer, Shohreh Amini, Flossie Wong‐Staal, Prasun K. Datta, Daniel Zagury, Houria Hendel, Jean‐François Zagury, Sidney Croul and Robert C. Gallo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Jay Rappaport

141 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A smartphone-read ultrasensitive and quantitative saliva test for COVID-19

2021 196 citations Bo Ning, Tao Yu et al. Science Advances profile →

Peers

Countries citing papers authored by Jay Rappaport

Since Specialization

Citations

This map shows the geographic impact of Jay Rappaport's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay Rappaport with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay Rappaport more than expected).

Fields of papers citing papers by Jay Rappaport

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay Rappaport. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay Rappaport. The network helps show where Jay Rappaport may publish in the future.

Co-authorship network of co-authors of Jay Rappaport

This figure shows the co-authorship network connecting the top 25 collaborators of Jay Rappaport. A scholar is included among the top collaborators of Jay Rappaport based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jay Rappaport. Jay Rappaport is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Association between IL-1β and IL-18 Levels, Gut Barrier Disruption, and Monocyte Activation during Chronic Simian Immunodeficiency Virus Infection and Long-Term Suppressive Antiretroviral Therapy 2024 ·International Journal of Molecular Sciences ·(unknown), Chenxiao Wang, (unknown), Brooke Grasperge, Prasun K. Datta, Jay Rappaport, Xuebin Qin, Namita Rout	0
2	HIV Protein Nef Induces Cardiomyopathy Through Induction of Bcl2 and p21 2024 ·International Journal of Molecular Sciences ·(unknown), (unknown), Nicole D. Ford, (unknown), Yuka Kimura, (unknown), (unknown), (unknown), (unknown), Rajkumar Ramalingam, Jay Rappaport, Manish Gupta	2
3	Upregulation of inflammatory genes and pathways links obesity to severe COVID-19 2024 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·(unknown), (unknown), (unknown), Chenxiao Wang, Zheng Chen, Shumei Liu, Cecily C. Midkiff, (unknown), (unknown), Fengming Liu, (unknown), Sharon Fox, Nicholas J. Maness, Jay Rappaport, Eric Lazartigues, Robert V. Blair, Jay K. Kolls, Franck Mauvais‐Jarvis, Xuebin Qin	4
4	COVID-19 and influenza infections mediate distinct pulmonary cellular and transcriptomic changes 2023 ·Communications Biology ·(unknown), (unknown), (unknown), (unknown), Zheng Chen, (unknown), (unknown), Guixiang Dai, Di Tian, Konrad Bach, Xiao‐Ming Yin, Vicki Traina‐Dorge, Jay Rappaport, Nicholas J. Maness, Robert V. Blair, Jay K. Kolls, Derek Pociask, Xuebin Qin	9
5	Epitranscriptomics of SARS-CoV-2 Infection 2022 ·Frontiers in Cell and Developmental Biology ·(unknown), Jay Rappaport, Prasun K. Datta	14
6	SARS-CoV-2 infection of the pancreas promotes thrombofibrosis and is associated with new-onset diabetes 2021 ·JCI Insight ·Mirza Muhammad Fahd Qadir, (unknown), Wandy L. Beatty, Dina Gaupp, Lara Doyle‐Meyers, Tracy Fischer, (unknown), Robert V. Blair, Rudolf P. Bohm, Jay Rappaport, Eric Lazartigues, Richard S. Vander Heide, Jay K. Kolls, Xuebin Qin, Franck Mauvais‐Jarvis	41
7	A smartphone-read ultrasensitive and quantitative saliva test for COVID-19 breakdown → 2021 ·Science Advances ·Bo Ning, Tao Yu, Shengwei Zhang, Zhen Huang, Di Tian, Zhen Lin, Alex Niu, Nadia Golden, Krystle Hensley, Breanna Threeton, Christopher J. Lyon, Xiao‐Ming Yin, Chad J. Roy, Nakhle S. Saba, Jay Rappaport, Qingshan Wei, Tony Hu	196
8	Anti-Cytokine Therapeutics: History and Update 2009 ·Current Pharmaceutical Design ·Rojo Ratsimandresy, Jay Rappaport, Jean-François Zagury	29
9	Culturing of human peripheral blood cells reveals unsuspected lymphocyte responses relevant to HIV disease 2008 ·Proceedings of the National Academy of Sciences ·Bita Sahaf, Kondala R. Atkuri, Kartoosh Heydari, Meena Malipatlolla, Jay Rappaport, (unknown), Leonard A. Herzenberg, Leonore A. Herzenberg	33
10	Macrophage Colony-Stimulating Factor in the Pathogenesis of HIV Infection: Potential Target for Therapeutic Intervention 2006 ·Journal of Neuroimmune Pharmacology ·(unknown), Tracy Fischer, Jay Rappaport	21
11	Dominant Effects of CCR2-CCR5 Haplotypes in HIV-1 Disease Progression 2004 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Cheryl A. Winkler, Houria Hendel, Mary Carrington, Michael W. Smith, George W. Nelson, (unknown), John Phair, David Vlahov, Lisa P. Jacobson, Jay Rappaport, Alexandre Vasilescu, Sébastien Bertin-Maghit, Ping An, Wei Lu, J Andrieu, (unknown), Amu Therwath, (unknown)	25
12	Internalization of Exogenous Human Immunodeficiency Virus-1 Protein, Tat, by KG-1 Oligodendroglioma Cells Followed by Stimulation of DNA Replication Initiated at the JC Virus Origin 2004 ·DNA and Cell Biology ·Dianne C. Daniel, Yayoi Kinoshita, (unknown), Luis Del Valle, Kamel Khalili, Jay Rappaport, Edward M. Johnson	32
13	Associations of MHC Ancestral Haplotypes with Resistance/Susceptibility to AIDS Disease Development 2003 ·The Journal of Immunology ·Pedro O. Flores-Villanueva, Houria Hendel, Sophie Caillat‐Zucman, Jay Rappaport, (unknown), Sébastien Bertin-Maghit, Jorge A Ruiz-Morales, (unknown), (unknown), Jean‐François Zagury	72
14	Neuroprotective Effects of IGF-I against TNFα-Induced Neuronal Damage in HIV-Associated Dementia 2002 ·Virology ·Jin Ying Wang, Francesca Peruzzi, Adam Lassak, Luis Del Valle, R. Sujatha, Jay Rappaport, Kamel Khalili, Shohreh Amini, Krzysztof Reiss	33
15	The sCYMV1 hairpin ribozyme: targeting rules and cleavage of heterologous RNA 1999 ·Gene Therapy ·Ying Lian, (unknown), (unknown), Arnold Hampel, Jay Rappaport	7
16	A prophylactic and therapeutic AIDS vaccine containing as a component the innocuous Tat Toxoid 1998 ·Biomedicine & Pharmacotherapy ·Hélène Le Buanec, A Lachgar, B Bizzini, (unknown), Jay Rappaport, Elena Santagostino, (unknown), A. Gringeri	12
17	Binding of HIV-1 to RBCs involves the Duffy Antigen Receptors for Chemokines (DARC) 1998 ·Biomedicine & Pharmacotherapy ·(unknown), (unknown), (unknown), B Bizzini, (unknown), Jay Rappaport, Daniel Zagury	46
18	Transport of phosphorothioate oligonucleotides in kidney: Implications for molecular therapy 1995 ·Kidney International ·Jay Rappaport, Basil Hanss, Jeffrey B. Kopp, Terry D. Copeland, Leslie A. Bruggeman, Thomas M. Coffman, Paul E. Klotman	101
19	Patterns of HIV-1 mRNA Expression in Transgenic Mice Are Tissue-Dependent 1994 ·Virology ·Leslie A. Bruggeman, Michael M. Thomson, Peter J. Nelson, Jeffrey B. Kopp, Jay Rappaport, Paul E. Klotman, Mary E. Klotman	34
20	Transcription Elongation Factor SII Interacts with a Domain of the Large Subunit of Human RNA Polymerase II 1988 ·Molecular and Cellular Biology ·Jay Rappaport, Ken Cho, Alan Saltzman, (unknown), Miriam Golomb, Roberto Weinmann	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact